BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24077352)

  • 1. Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma.
    Hua Y; White-Gilbertson S; Kellner J; Rachidi S; Usmani SZ; Chiosis G; Depinho R; Li Z; Liu B
    Clin Cancer Res; 2013 Nov; 19(22):6242-51. PubMed ID: 24077352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma.
    Chhabra S; Jain S; Wallace C; Hong F; Liu B
    J Hematol Oncol; 2015 Jun; 8():77. PubMed ID: 26108343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1.
    Usmani SZ; Bona RD; Chiosis G; Li Z
    J Hematol Oncol; 2010 Oct; 3():40. PubMed ID: 20977755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.
    Doudican NA; Wen SY; Mazumder A; Orlow SJ
    Oncol Rep; 2012 Nov; 28(5):1851-8. PubMed ID: 22922937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α7 helix region of αI domain is crucial for integrin binding to endoplasmic reticulum chaperone gp96: a potential therapeutic target for cancer metastasis.
    Hong F; Liu B; Chiosis G; Gewirth DT; Li Z
    J Biol Chem; 2013 Jun; 288(25):18243-8. PubMed ID: 23671277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine but not human basophil undergoes cell-specific proteolysis of a major endoplasmic reticulum chaperone.
    Liu B; Staron M; Li Z
    PLoS One; 2012; 7(6):e39442. PubMed ID: 22724016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic alterations induced by partial hepatectomy: Upregulation of glycoprotein 96, CD91 and TLR2 and generation of regulatory T cells.
    Jakovac H; Ćuk M; Trobonjača Z; Mrakovčić-Šutić I; Radošević-Stašić B
    Histol Histopathol; 2015 Aug; 30(8):931-43. PubMed ID: 25693689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.
    Sagawa M; Ohguchi H; Harada T; Samur MK; Tai YT; Munshi NC; Kizaki M; Hideshima T; Anderson KC
    Clin Cancer Res; 2017 Sep; 23(17):5225-5237. PubMed ID: 28442502
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.
    Mimura N; Fulciniti M; Gorgun G; Tai YT; Cirstea D; Santo L; Hu Y; Fabre C; Minami J; Ohguchi H; Kiziltepe T; Ikeda H; Kawano Y; French M; Blumenthal M; Tam V; Kertesz NL; Malyankar UM; Hokenson M; Pham T; Zeng Q; Patterson JB; Richardson PG; Munshi NC; Anderson KC
    Blood; 2012 Jun; 119(24):5772-81. PubMed ID: 22538852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis.
    Rachidi S; Sun S; Wu BX; Jones E; Drake RR; Ogretmen B; Cowart LA; Clarke CJ; Hannun YA; Chiosis G; Liu B; Li Z
    J Hepatol; 2015 Apr; 62(4):879-88. PubMed ID: 25463537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRP94/gp96 in Cancer: Biology, Structure, Immunology, and Drug Development.
    Wu BX; Hong F; Zhang Y; Ansa-Addo E; Li Z
    Adv Cancer Res; 2016; 129():165-90. PubMed ID: 26916005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained production of spliced X-box binding protein 1 (XBP1) induces pancreatic beta cell dysfunction and apoptosis.
    Allagnat F; Christulia F; Ortis F; Pirot P; Lortz S; Lenzen S; Eizirik DL; Cardozo AK
    Diabetologia; 2010 Jun; 53(6):1120-30. PubMed ID: 20349222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XBP1S protects cells from ER stress-induced apoptosis through Erk1/2 signaling pathway involving CHOP.
    Guo FJ; Liu Y; Zhou J; Luo S; Zhao W; Li X; Liu C
    Histochem Cell Biol; 2012 Sep; 138(3):447-60. PubMed ID: 22669460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15d-PGJ
    Sperandio M; Demasi APD; Martinez EF; Saad SO; Pericole FV; Vieira KP; Freitas NS; Araújo VC; Brown AL; Clemente-Napimoga JT; Napimoga MH
    Exp Mol Pathol; 2017 Jun; 102(3):434-445. PubMed ID: 28506771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic ER stress suppresses β-catenin expression and promotes cooperation between the transcription factors XBP1 and HIF1α for cell survival.
    Xia Z; Wu S; Wei X; Liao Y; Yi P; Liu Y; Liu J; Liu J
    J Biol Chem; 2019 Sep; 294(37):13811-13821. PubMed ID: 31350332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.
    Pal R; Janz M; Galson DL; Gries M; Li S; Jöhrens K; Anagnostopoulos I; Dörken B; Mapara MY; Borghesi L; Kardava L; Roodman GD; Milcarek C; Lentzsch S
    Blood; 2009 Oct; 114(18):3890-8. PubMed ID: 19717648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
    Nardiello T; Jungbluth AA; Mei A; Diliberto M; Huang X; Dabrowski A; Andrade VC; Wasserstrum R; Ely S; Niesvizky R; Pearse R; Coleman M; Jayabalan DS; Bhardwaj N; Old LJ; Chen-Kiang S; Cho HJ
    Clin Cancer Res; 2011 Jul; 17(13):4309-19. PubMed ID: 21565982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
    Nishimura N; Radwan MO; Amano M; Endo S; Fujii E; Hayashi H; Ueno S; Ueno N; Tatetsu H; Hata H; Okamoto Y; Otsuka M; Mitsuya H; Matsuoka M; Okuno Y
    Cancer Sci; 2019 Oct; 110(10):3275-3287. PubMed ID: 31368616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells.
    Lee AH; Iwakoshi NN; Anderson KC; Glimcher LH
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9946-51. PubMed ID: 12902539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.